IRIS PubliCatt

Baranello, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.469
NA - Nord America 1.361
AS - Asia 409
AF - Africa 12
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 3.262
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.348
DE - Germania 631
SE - Svezia 229
CN - Cina 163
IT - Italia 136
SG - Singapore 108
IE - Irlanda 93
UA - Ucraina 93
FR - Francia 78
GB - Regno Unito 70
ID - Indonesia 58
RU - Federazione Russa 39
IN - India 34
FI - Finlandia 30
BE - Belgio 17
TR - Turchia 14
MK - Macedonia 12
RS - Serbia 10
CH - Svizzera 9
HK - Hong Kong 9
NL - Olanda 8
CA - Canada 7
CI - Costa d'Avorio 5
EG - Egitto 5
IR - Iran 5
KR - Corea 5
PA - Panama 5
PL - Polonia 5
BR - Brasile 4
CZ - Repubblica Ceca 4
IL - Israele 4
PE - Perù 3
PH - Filippine 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
AU - Australia 1
DK - Danimarca 1
ES - Italia 1
JP - Giappone 1
LU - Lussemburgo 1
MA - Marocco 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
SC - Seychelles 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.262
Salva come PNG Salva come JPEG
Città #
Chandler 311
Ashburn 106
New York 100
Dublin 76
Singapore 73
Jacksonville 67
Jakarta 58
Ann Arbor 55
San Mateo 47
Nürnberg 40
Dearborn 38
Marseille 36
Wilmington 34
Nanjing 33
Seattle 33
Milan 31
Boston 25
Moscow 25
Munich 21
Woodbridge 21
Princeton 20
Rome 20
Houston 18
Fairfield 17
Lancaster 17
Bremen 16
Beijing 15
Los Angeles 15
Nanchang 15
Brussels 14
Augusta 12
Lawrence 12
Palermo 12
Leawood 10
Pune 10
Redwood City 10
Skopje 10
Hangzhou 9
Norwalk 9
Hebei 8
Hong Kong 8
Changsha 7
Chicago 7
Jinan 7
Boardman 6
Cambridge 6
Fremont 6
Helsinki 6
Jiaxing 6
Menlo Park 6
Ningbo 6
Niš 6
Abidjan 5
Cattolica 5
Hefei 5
Izmir 5
Shenyang 5
Washington 5
Amsterdam 4
Bern 4
Harrisburg 4
Kish 4
Lappeenranta 4
London 4
Paris 4
Seoul 4
Tianjin 4
Zhengzhou 4
Basel 3
Brno 3
Busto Arsizio 3
Cairo 3
Dallas 3
Detroit 3
Easton 3
Edinburgh 3
Kiel 3
Kunming 3
Lima 3
Mountain View 3
South Hadley 3
University Park 3
Andover 2
Ankara 2
Ashdod 2
Atlanta 2
Bauang 2
Belgrade 2
Buffalo 2
Calgary 2
Cinisello Balsamo 2
Costa Mesa 2
Delianuova 2
Florence 2
Frankfurt am Main 2
Genoa 2
Guangzhou 2
Istanbul 2
Kazan' 2
Milazzo 2
Totale 1.724
Salva come PNG Salva come JPEG
Nome #
Cortical visual function in preterm infants in the first year. 207
Neurological examination at 6 to 9 months in infants with cystic periventricular leukomalacia 162
Prognostic value of EEG performed at term age in preterm infants. 152
-Thalamic atrophy in infants with PVL and cerebral visual impairment 139
Visual development in prenatal post-haemorragic ventricular dilatation 123
Antenatal post-hemorragic ventriculomegaly: a prospective follow-up study 123
External hydrocephalus in discordant birth weight twins: a case report 121
Sleep disturbances in preschool age children with cerebral palsy: a questionnaire study 114
Early development in Dravet syndrome; visual function impairment precedes cognitive decline 112
Sleep disturbances in preschool age children with cerebral palsy: a questionnaire study 102
Cardiac Function in Types II and III Spinal Muscular Atrophy: Should We Change Standars of Care? 98
Visual processing in Noonan syndrome: dorsal and ventral stream sensitivity 97
antenatal post hemorrhagic ventriculomegaly: a prospective follow up study 87
Visual processing in Noonan syndrome: dorsal and ventral stream sensitivity 84
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 76
Timed Rise from Floor as a Predictor of Disease Progression in Duchenne Muscular Dystrophy: An Observational Study 73
Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data. 73
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial 71
Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamol 70
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 66
6 minute walk test in duchenne MD patients with different mutations:12 month changes 65
Different trajectories in upper limb and gross motor function in spinal muscular atrophy 65
Revised north star ambulatory assessment for young boys with Duchenne muscular dystrophy 64
SMA-miRs (MiR-181a- 5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples 64
SMA-miRs (MiR-181a- 5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples 59
Registries versus tertiary care centers: How do we measure standards of care in Duchenne muscular dystrophy? 58
Longitudinal natural history in young boys with Duchenne muscular dystrophy 58
Implicit learning deficit in children with Duchenne muscular dystrophy: Evidence for a cerebellar cognitive impairment? 57
The nonsense mutation stop+4 model correlates with motor changes in Duchenne muscular dystrophy 51
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 49
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls 48
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls 47
Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy 45
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 42
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo-controlled, dose-finding trial followed by 24 months of treatment 40
Risdiplam in Type 1 Spinal Muscular Atrophy 37
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls 35
Development of an International SMA Bulbar Assessment for Inter-professional Administration 28
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA Participants 27
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial 25
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 23
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls 21
Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study 18
The emerging spectrum of neurodevelopmental comorbidities in early-onset Spinal Muscular Atrophy 17
Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial 17
Erratum: Long term natural history data in ambulant boys with duchenne muscular dystrophy: 36-month changes (PLoS ONE (2015) 10:12 (e0144079)) 15
Longitudinal data of neuropsychological profile in a cohort of Duchenne muscular dystrophy boys without cognitive impairment 14
Diagnosis of Duchenne Muscular Dystrophy in Italy in the last decade: Critical issues and areas for improvements 11
Genetic modifiers of upper limb function in Duchenne muscular dystrophy 11
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 9
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 9
Genetic modifiers of respiratory function in Duchenne muscular dystrophy 8
Severe abnormalities of the pons in two infants with Goldenhar syndrome 7
Visual development in infants with prenatal posthaemorrhagic ventricular dilatation 5
Correction: Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 (PLoS ONE (2019) 14:6 (e0218683) DOI: 10.1371/journal.pone.0218683) 5
Cognitive profile in Duchenne muscular dystrophy boys without intellectual disability: The role of executive functions 4
The neurological examination of the newborn baby 4
Visual findings in infants with periventricular leukomalacia: 139 3
Totale 3.315
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.249
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.249
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020306 0 0 35 16 33 41 55 10 30 23 43 20
2020/2021211 19 25 3 18 18 13 31 5 29 16 31 3
2021/2022384 19 17 19 41 25 15 7 64 29 23 61 64
2022/2023931 104 124 59 144 54 112 45 79 136 10 40 24
2023/2024610 31 126 18 39 21 132 59 18 5 23 63 75
2024/2025141 24 25 92 0 0 0 0 0 0 0 0 0
Totale 3.315